BioAcoustic Biology Research Studio
  • HOME
  • About
  • Contact
  • APPLICATIONS
    • CASE STUDY CLIENT RELEASE FORM
    • CLIENT RESEARCH DATA APPLICATION
    • RESEARCH SUBJECT-CLIENT EQUIPMENT WAIVER
    • REQUIREMENTS FOR SUBMITTING A VOCAL PROFILE
    • DISCOUNTS
  • ARTICLES
    • REAL NEWS >
      • HEALTH NEWS
      • VACCINE NEWS
      • CANCER NEWS
      • EBOLA NEWS
    • GMO NEWS >
      • GMO SHOCK THERAPY
      • HOW WE'RE WINNING THE GMO BATTLE
      • STUDY FINDS LINK BETWEEN GMO'S AND HEALTH CRISIS
      • ALTERED GENES, TWISTED TRUTH
    • "SELF HEALING" MUSIC
    • WHAT IS BIOACOUSTIC BIOLOGY >
      • WHAT IS SOUND PRESENTATION
      • WHAT IS VOCAL PROFILING
      • UNDERSTANDING A VOCAL PROFILE REPORT
      • VOICE, A HOLOGRAPHIC REPRESENTATION OF SELF
      • AT&T ANNOUNCES BIOACOUSTICS AS "THE MEDICINE OF THE FUTURE"
      • IS FREQUENCY OUR NEW MEDICINE OR AN ANCIENT MYSTERY REVEALED
      • IF YOU CAN MOAN, YOU CAN TONE
      • TIME TO GIVE BACK
    • BIOACOUSTIC BIOLOGY RESEARCH INSTITUTE >
      • JBAB VOL 9 #10
    • DNA CAN BE INFLUENCED AND REPROGRAMMED BY WORDS & FREQUENCIES
    • SUBSTANCES THAT DESTROY NUTRIENTS
    • ZERO-CALORIE SWEETENERS MAY TRIGGER BLOOD SUGAR RISK
  • MICHIGAN SKY WATCHERS
  • MICHIGAN & OHIO LOCAL & SUGGESTIONS
  • SMART METERS MICHIGAN
    • CAMP TRUTH
  • DISCLAIMER
    ~~~ STUDY FINDS LINKS BETWEEN GMO'S AND HEALTH CRISIS   ~~~
Are
 pesticide 
resistant
 seeds 
responsible
 for 
cell
 signaling
 malfunctions?

The
 August
 14th, 
2010
 issue
 of 
Science 
News, 
”Separating 
wheat
 from
 chaff 
in
 celiac
 disease”,
 reported that
 a
 research
 

team
 led
 by
 gastroenterologist
 Robert
 Anderson
 of
 the
 Walter
 and
 Eliza
 Hall
 Institute
 of Medical
 Research
 in
 Parkville, 
Australia,
 had
identified 
specific
triggers
 (gluten
sen sensitivities)
 associated with
 celiac
 disease. 

These
 following
 observations
 are
 based
 on
 the
  mathematical matrix
 of
 BioAcoustic
 Biology
 developed
 over
 the
 last
 twenty years
 by
 the
Sound
 Health
 Research
 Center
 located
 in
 Albany, Ohio,
 USA.

 The
 system
 allows
 for
 the evaluation
 of
 

any
 aspect of
 the
 body
 and
 biochemistry
 in
 terms
 of
 numeric 
mathways, aka
 Frequency
 Equivalents™. 

Research 
efforts
 at
 the
 Institute
 of
 BioAcoustic
 Biology 
often evaluate
 clients
 who
 exhibit
 gluten
 sensitivity
 along
 with
 a myriad
 of
 associated diseases. 

In 
light
 of 
this
 new 
information it
 was
 imperative 
that
 this
 data
 be
 added
 to
 their
 an analytical software
 data bases.
 The
 three
 proteins
 identified
 by
 the Anderson
 study
 were 
translated 
into
 BioAcoustic
 bio‐frequency
 biomarkers*.

 The
 resulting
 numeric
 matrix 
showed that 
the
 metabolic 
pathways 
influenced
 by
 these
 proteins 

were 
linked 
to
 nearly
 all
 systems
 of
 the
 human
 body;
 causing immune 
distortion,
 acute
 cellular 
inflammation
 and disruptions 
in
 cell
 communication.  

The 
original
 article
 listed
 three
 proteins,
 w‐5
 gliadin
 (wheat),  g‐3
 hordein
 (barley)
 and
 g
 secalins
 (rye)
 that 
were
 implicated 

in
 the 
production
 of
 specific
 anti‐gliadin 
antibody
 reactions.

 These
 proteins,
 which
 have
 been 
proven 
to be
 responsible 

for
 allergic
 reactions, 
 are 
associated
 with
 grain
 glutens 
from 
which
 they
 are
 derived. 

Patent
 records 
indicated
 many
 grains
 seeds 
being
 produced 
for
 market 
are
 GMO’ 
developed
 and patented
 by
 a
 multinational
 agricultural
biotech
 conglomerate
 that 
is
 attempting 
to
 make 
their
 grains  impervious to weed killers.  Could this confirm that the present day epidemic of grain related sensitivities/allergies stem from laboratory modified seeds.

These
 distorted,
 allergy
 causing,
 “engineered”
 grains 
are
 being
 used
 to
 create
 foods
 that
 we 
eat everyday; 
bread,
 cereals,
 chips,
 crackers,
  pastry,
 seasonings,
 even 
some 
packaged
 chip
 products
 contain gluten.

  BioAcoustic
 Biology
 matrix
 correlations
 revealed
 how
thoroughly 
our
 health
 is
 being
 negatively influenced
 by
 these
 genetically
 modified
 foods
 (GMO’s).

Further 
investigation
 revealed
 that
 the
 engineered
 grains
 contain
 two
 substitutions
 that
 distorted
 the way
 the
 body
 processes
 two
 sulfur
 rich
 amino 
acids:
 proline
 and
 glutamine.

  Disturbances
 in 
these amino
 acid
 substitutions
 result
 in
 the
 impedance
 of
 the 
methylation
 of
 these
 two
 essential
 nutrients.

BioAcoustically
 speaking,
 Glutamine
 distortions
 seem
 to
 be
 the
 most
 destructive.

  The
 enzyme
 required to
 utilize
 glutamine
 is
 glutamate
decarboxylase 
(GAD).

  Glutamate
 is
 a
 key
 molecule
 in
 cellular metabolism
 and
 the
 most
 abundant
 excitatory
 neurotransmitter
 in
 a 
vertebrate
 nervous
 system.

In
 mammals,
 GAD
 exists 
in
 two
 isoforms
 encoded
 by 
two
 different
 genes
 ‐
 Gad 1
 and
 Gad 2.
  
GAD 1
 and GAD 2
 are
 

expressed
 in
 the
 brain
 where
 GABA
 is 
used
 as
 a
 neuro transmitter;
 GAD 2
 is
 also
 expressed
 in the
 pancreas.

This
 led
 to
 an
 evaluation
 of
 the
 GAD 
genomes
 and
 what
 happens
 when
 these
 genes
 are 
activated:

Glutamate
 decarboxylase
 aka
 glutamic
 acid
  decarboxylase
 (GAD)
 is
 a n
enzyme
 that
 catalyzes
 the decarboxylation
 (part
 of
 

the 
process
 of
 breaking
 down
 for
 use
 by
 the
 body)
 of
 glutamate
 to
 GABA (gamma
 aminobutyric
 acid)
 and
 CO2.

GABA
 is
 a
 natural
 tranquilizer
 and
 an
 important
 inhibitory 
neurotransmitter
 that
 helps
 regulate
 neuronactivity
 and
 the
 body’s
 nanosensors.

 Starting
 with
 the
 GAD
 enzyme
 response
 and
 moving
 toward
 GABA in 
conjunction
 with
 the
 active
 form
 of
 B6
 (PLP),
 the
nanotransmitters
 of
 the
 body
 are
 created
 and regulated.

 The 
movement
 of
 electrical
 energy
 and 
hence
 magnetic
 potential
 within
 the
 body
 are controlled
 by 
these
 nanotransmitters.

GAD
 uses
 PLP
 (pyridoxal
 50 ‐ phosphate)
 as
 a
 cofactor.

  PLP
 was
 granted
 a
 patent
 by
 the
 US 
government patent
 office
 to
 

the
 Canadian
 company,
 Medicure.

  PLP
 is
 now
 under
 the
 control
 of
 the
 pharmaceutical industry
 and
 its
 lack
 is
 often
 associated
 with
 blood
 clotting
 distortions,
 migraines,
 neural
 disorders
 and seizures.

Nanotransmitters 
produced
 in
 conjunction
 with
 GAD
 metabolism
 show
 direct
 associations
 with
 a multitude
 of
 diseases:
 diabetes,
 autism,
 arthritis,
 Parkinson's,
 ALS,
 Multiple
 Sclerosis,
 joint
pain
and deterioration, 
auditory
 disorders,
 Celiac 
Disease,
 Crohns,
 Irritable
 Bowel
syndrome, diverticulitis, schizophrenia,

 bipolar
 and
 anxiety
 disorders,
 aspartame
 

sensitivity,
 MSG
 reactions,
 Lupus,
Fibromyalgia, depression,
 seizures,
 brain
 signaling,
 the
 use
 of
 calcitonin 
(cancer
related),
 histidine
 function
 (seasonal allergies),
 cellular
inflammation
and
 vaccination
 reactions.

Of
 particular 
importance
 is
 GAD’s
 involvement
 with 
cancer
 via
 Calcitonin,
 a
 32–amino‐acid peptide/hormone
 that 


participates
 in
 calcium
 and
 phosphorus
 metabolism.


 BioAcoustically
 speaking, calcitonin
 is 
a 
major
 player
 in
 the
 role
 
of
 how
 the 
body
 handles
 any
 cancer 
threat.

Parkinson’s
 is
 an 
incurable,
 debilitating
 disease
 that
 also
 shows
 GAD
 involvement.
 The
 activity
 of glutamic
 acid
 decarboxylase
 (GAD),
 the
 enzyme
 involved
 in
formation
 of
 the
 inhibitory 
neuro transmitter γ‐aminobutyric
 acid
 (GABA),
 

was 
studied
 in
 autopsy 
brain 
samples
 from
 six
 Parkinson's
 patients
 and
 13 controls.
  The
 activity
 of
 GAD
 was
 significantly
 reduced
 in
 brain
 samples
 of
 patients
 with
 Parkinson’s disease,
 being
 about
 50
 percent
 of
 that
 in
 controls.
 Moreover,
 levodopa
 treatment 
showed
 a
 tendency to
 increase
 the
 activity
 of
 GAD.
 The
 results
 suggest
 the 
involvement
 of
 GABA
 neurons
 in
 Parkinson’s disease.

A
 search 
of 
the 
GAD 
literature 
stated 
that 
acetylcholine, 
γ‐aminobutyric 
acid,
 dopamine, 
calcitonin 
gene‐related
 peptides,
 choline
acetyltransferase 
and 
enkephalins 
are 
involved 
with 
the 
metabolism 
of 
GAD. 

It would 
be 
important 
to 
include 
these 
biochemicals 
when
testing
 subjects
 for
 GAD 
presence
 and methylation.

Glutamate 
is 
the 
same 
Frequency
 Equivalent* 
as
aspartame 
and 
is 
part 
of 
MSG 
(mono‐sodium glutamate). 

James
 Oschman
 

in
 his 
publication, 
Energy 
Medicine, 
states 
that 
cells 
emit 
frequency‐based signals 
as 
a
re quest 
for 
needed
 biochemicals 

to
 gather 
at 
the 
site
where 
they
 are 
needed.
 Since Glutamate
 and
 Aspartame
 are
 the
 same
 frequency,
 this
 may
 explain
 why
 Aspartame
 has
 been implicated
 in
 so
 many
 muscle
 and
 joint
 disorders. 

MSG
 is
 also 
used
 as
 a
 stabilizer
 in
 some
 vaccines.

 This
 could
 account
 for
 the
 reported 
increase
 in 
autism associated
 vaccination 
damage.

"This
 may
 be
 one
 of 
the decade’s
 most important “connections”
 between food
 and
 genetics. 
By showing
 the
 frequency relationships
among substances
 normally found
 in
 healthy people,
 you 
have confirmed
 that
 the potential
 for
 

GMO  harm
 is
 very
 real."  States Ralph 
Fucetola
, JD and health freedom advocate.

Sharry
Edwards, 
the 
recognized 
pioneer
 of 
this 
emerging 
technology 
states, 
“I
expect 
this 
information will
 be 
the 
impetus 


that
 opens
 the
 world
 to
 the
 potential
 of 
BioAcoustic
 Biology
 and
 the
 hope
 of allowing
 access
 to
 Self
 Health
 care
 via
 
easy‐to‐use
 software; 
even
 after
 the
 appearance
 of
 a
 disease process”.

From
 the
 original
 Science
 News 
article:

“Three
 protein 
fragments 
are 
looking 
like 
the 
guilty 
parties 
in 
celiac
 disease,
 an 
intestinal 
ailment 
that affects
 as 
many

 
as 
one 
in 
133 
people 
in 
the 
United 
States. 
These
 partial 
proteins, 
or 
peptides, 
are 
the part 
of 
gluten 
in 
wheat, 
rye 
and 

barley 
that 
triggers 
the 
immune 
systems
 of
 celiac
 patients, 
damaging the
 small 
intestine.
 An
 Australian
 research
 team
 
reports
 the
 new
 findings 
in
 the
 July
 2 Science Translational
 Medicine.”

“This
 is
 an
 impressive
 and
 very
 comprehensive
 study, ”
says 
immunologist 
Ludvig
 Sollid
 of
 the
 University of
 Oslo.
 

“The 
authors
 find
 that
 most
 celiac
 patients 
make
 a
 response
 to
 these
 three
 gluten
 peptides.”

Questions:
  Are
GMO
 producers
 aware
 of
 the
 damage
 to
 health
 that
 is
 being
 caused?

 Shouldn’t
 those with
 cell
 signaling 
issues
 be
 warned
 about
 ingesting
 these
 glutens?

 Why
 are
 GMO
 producers
 and
 the US
 government
 boldly
 attempting
 to
 prevent 
package
 warnings
 that
 would
 notify 
people
 that 
they were 
eating 
GMO 
products? 
Is 
it 
greed, 
ignorance 
or 
a 
misguided
 attempt
 to
 improve
 our 
food 
supply that
 is
 in
 fact
 poisoning 
our 
food, 
our 
population,
 and 
our 
genetic 
pool? 



Is 
this 
assault
 on 
our 
food supply
 intentionally 
creating 
a 
future 
that 
will 
keep 
us 
ill 
and 
medication 
dependent?

For 
further
 information
 about 
this
 topic,
 or
 to
 schedule
 an 
interview
 with
 Sharry 
Edwards, 
please
 call  740‐698‐9119
    M‐F,  
EST
 or
 write
 to 
[email protected]  References
 available
 by
 request.

*
All
 issues
 expressed
 in
 terms
 of 
Frequency 
Equivalent™
 (a
“term 
of 
use” 
for 
BioAcoustic Biology) a numeric 


representation
 of
 a
 person,
 place,
 thing 
or
 emotion.

Institute
 of 
BioAcoustic
 Biology
 and
 Sound
 Health
Contact:
 Sharry
 Edwards,
  MEd.
 
 
 
 
 FOR  
IMMEDIATE
  RELEASE
740‐698‐9119

 
 
 
 
 
 
 December
 26,
 2010
[email protected]
 
 
 
 
 
 SoundHealthOptions.com

Reference 
articles/abstracts/Links

Ann
 Rheum 
Dis. 
2008 
Jul;67(7):1051‐2. 
Methotrexate 
and 
its 
effect 
on 
the 
anti‐GAD 
titre 
in 
two 
patients with 
rheumatoid 
arthritis 
and
diabetes 
 mellitus. 
van 
Deutekom
 AW, 
Nurmohamed 
MT, 
Peters 
MJ, 
van Eijk 
IC, 
Dijkmans 
BA, 
Hamann 
D, 
Heine 
RJ, 
Simsek 
S.

Anti‐GAD‐positive 
patients 
with 
type 
1 
diabetes 
mellitus 
have 
higher 
prevalence 
of 
autoimmune thyroiditis 
than 
anti‐GAD‐negative 
patients 
with 
type 
1 
and 
type 
2 
diabetes 
mellitus.
 
Bárová 
H,  Perusicová
 J, 
Hill 
M, 
Sterzl
I, 
Vondra
 K, 
Masek 
Z. 
Third 
Department 
of
Medicine,
 General
 University Hospital,
 First 
Faculty
 of 
Medicine, 
Charles 
University, 
Prague,
 Czech 
Republic
























































Arch
 Neurol.
 2004; 61:902‐904. GAD
 and
 Lupus/Fibromyalgia 

Archives 
of 
Neurology 
– 
Vol 
61, 
No 
6, 
June 
2004. 
Anti–Glutamic 
Acid 
Decarboxylase 
Antibodies
 in 
the Serum
and 
Cerebrospinal 
Fluid 
of
Patients
 With
 Stiff ‐ Person
 Syndrome.
 Goran
 Rakocevic,
 MD;  Raghavanpillai
 Raju,
 PhD;
  Marinos
 C.
 Dalakas,
 MD.

Autoantibodies 
in 
patients 
with 
gut
 motility 
disorders 
and 
enteric 
neuropathy. 
Törnblom 
H, 
Lang 
B,  Clover 
L,  
Knowles
 CH, 
Vincent 
A, 
Lindberg
 G. 
Karolinska 
Institutet, 
Department
 of 
Medicine, 
Karolinska University 
Hospital, 
Huddinge, 
Stockholm, 
Sweden

Biochemical
 Medicine.
 Volume
 21, 
Issue
 1,
 February
 1979, 
Pages 
22‐32

Blaylock, 
MD, 
Russel 
L. 
"The 
Connection 
Between 
MS 
and 
Aspartame
. "
Truth
 In 
Labeling. 
N. p., 
06
07 2004.
Web. 
26 
Sept 
2010.
<http://www.truthinlabeling.org/Blaylock‐AspartameAndMultipleSclerosis‐ Neurosurgeon%27sWarning.html

Clinical
 & 
Experimental 
Allergy. 
Volume
 40, 
Issue 
5, 
pages 
820–830,
 May 
2010. 
The 
role 
of 
interleukin‐ 4Rα 
in 
the 
induction 


of 
glutamic
acid 
decarboxylase 
in 
airway
 epithelium 
following 
acute 
house 
dust mite 
exposure. 
J.
A. 
Hirota, 
A. 
Budelsky,
 D.
 Smith, 
B. 
Lipsky, 
R. 
Ellis,
 Y‐Y. 
Xiang, 
W‐Y. 
Lu, 
M.
D. 
Inman 
5

Clinical 
and 
Experimental 
Medicine 
Volume
 3, 
Number 
1, 
32‐36, 
DOI: 
10.1007/s102380300013.  Anticardiolipin, 
glutamic 
acid
decarboxylase,
 and 
antinuclear 
antibodies 
in 
epileptic 
patients 
A. 
Verrotti, R. 
Greco, 
E. 
Altobelli, 
G. 
Latini, 
G. 
Morgese
 

and 
F. 
Chiarelli.

Decreased 
GAD67 
mRNA 
levels
 in
 cerebellar 
Purkinje 
cells 
in 
autism:
 pathophysiological 
implications. Jane 
Yip, 
Jean‐Jacques
Soghomonian 
and 
Gene 
J. 
Blatt 

Diabetes 
mellitus 
decreases 
the 
expression 
of 
calcitonin‐gene 
related 
peptide, 
gamma‐amino 
butyric acid 
and 
glutamic 


acid
decarboxylase 
in 
human
 pancreatic
 islet 
cells. 
Al‐Salam
 S, 
Hameed
 R, 
Parvez 
HS,  Adeghate 
E

Direct
 and 
indirect 
cellular 
effects 
of 
aspartame
 on 
the 
brain. 
Humphries
 P, 
Pretorius 
E, 
Naudé  H. Department 
of 
Anatomy, 
University 
of
Pretoria,
 Pretoria,
 Gauteng,
 South
 Africa.

Eur 
J 
Clin 
Nutr. 
2008 
Apr; 62(4):451‐62.
 Epub 
2007 
Aug.

European
 Neurlogy 
– 
Vol 
12, 
No. 
1, 
1974. 
Brain 
Glutamic 
Acid 
Decarboxylase 
Activity 
in 
Parkinson’s Disease. 
U.K .


Rinne, 
H. 
Laaksonen,
P. 
Riekkinen, 
V. 
Sonninen. 
Department 
of 
Neurology, 
University 
of  Turku,
 Turku.

 Eur 
Neurol 
1974; 12:13‐19 (DOI:
10.1159/000114599)

Fasano,
 Alessio. 
"Celiac 
Disease 
Insights: 
Clues
to 
Solving 
Autoimmunity."  
Scientific 
American
 Magazine August 
2009:
 

n. 
pag. 
Web. 
25
Oct 
 2010. 
<http://www.scientificamerican.com/article.cfm?id=celiac‐ disease‐insights>

"Frequency 
o f
Autoantibodies 
in 
Celiac 
Disease. "
Celiac 
Disease
 Diagnosis, 
Testing 
& 
Treatment. 
Adams,  

Jefferson. 
N.p., 
1
29
2010.
Web.
 26 
Sept 
2010. 
<http://www.celiac.com/articles/22001/1/Frequency‐of‐ 
Autoantibodies‐in‐Celiac‐Disease/Page1.html>.

GAD
 and 
Irritable 
Bowel 
Syndrome. 
Scand 
J 
Gastroenterol. 
2007 
Nov; 42(11):1289‐93

"GlutamicAcid:Facts,DiscussionForum,andEncyclopediaArticle."AbsoluteAstronomy.Web.<http://www.absoluteastronomy.com/topics/Glutamic_acid

Internationa l
Archives 
of 
Allergy 
and 
Immunology 
– 
Vol 
152, 
No 
2, 
2010: 
The 
Diabetic 
Antigen 
Glutamic Acid 
Decarboxylase 
(GAD
65) 
in
the
 Human 
Peripheral
 Blood. 
G.P. 
Tilz, 
J. 
Dausset,
 M. 
Wiltgen

J
  Diabetes 
Sci 
Technol. 
2009 
March; 
3(2):
320–330.
Published 
on line 
2009 
March.

Journal
 of 
the 
Neurological 
Sciences, 
Volume
 47, 
Issue 
3, 
September 
1980, 
Pages
 353‐364 
Abnormalglutamic 
acid 
metabolism
in
multiple
sclerosis.
 A. 
Westall, 
G. Hawkins, 
W. 
Ellison, 
Lawrence
 W. 
Myers

Journal
 of 
Neurological 
Sciences
 ‐ 
Volume 
250, 
Issue 
1, 
Pages 
124‐132 
(1 
December 
2006). 
GABA 
A‐receptor 
mRNA 
expression 
in 
the
prefrontal 
and 
temporal 
cortex 
of 
ALS 
patients.
 S. 
Petria, 
K. 
Kollewea, C. 
Grotheb, 
A
Horic, 
R 
Denglera, 
J 
Buflera,
 K. 
Krampfla

"Listing 
Pathways. "
N.p., 
n.d. 
Web. 
26 
Sept 
2010. 
<http://pathman.smpdb.ca/pathways/SMP00072

Lupus. 
2005; 14(6):486‐8. 
Anti‐glutamic 
acid 
decarboxylase 
antibodies 
in 
a 
patient 
with 
systemic
 lupus  erythematosus
 and 
fibromyalgia
symptoms.
 Taylor‐Gjevre 
RM, 
Gjevre
 JA. 
Division 
of 
Rheumatology, Royal 
University 
Hospital, 
University 
o f
Saskatchewan, 
Saskatoon,
SK, 
Canada.

Mol
 Psychiatry. 
2006 
Aug; 11(8):752‐62. 
Epub 
2006 
May 
23. 
Association 
between 
glutamic 
acid  decarboxylase
 genes 
and 
anxiety
disorders, 
major
 depression, 
and 
neuroticism.
 Hettema
 JM, 
An 
SS,  Neale 
MC, 
Bukszar
 J, 
van
 den 
Oord 
EJ, 
Kendler 
KS, 
Chen 
X.
Department
 of 
Psychiatry, 
Virginia
 Institute for 
Psychiatric 
and 
Behavioral 
Genetics,
 Virginia 
Commonwealth 
University, 
Richmond, 
VA
23298‐0126, USA

Neurology.
 1971 
Oct; 21 (10): 1000‐7. Title: 
Glutamic 
acid 
decarboxylase 
in 
Parkinson's 
disease
 and epilepsy. McGeer 
PL, 
McGeer 
EG,
Wada
 JA

The 
Salk 
Institute, 
San 
Diego, 
CA  
U.S.A..
 Multiple
 Sclerosis 
Research 
Clinic, 
Department 
of 
Neurology, UCLA
 School
 of 
Medicine, 
Los
Angeles,
 CA
 U.S.A.

 <http://www.sciencedirect.com>

Physiol
 Res. 
2004; 53(3):279‐86.

Possible
 implication
 of
 an 
inosinetri phosphate
 metabolic
 error
 and 
glutamic 
acid
 decarboxylase 
in paranoid
 schizophrenia. 
Bernardo 
S.
Vanderheiden.
 Eastern 
Pennsylvania 
Psychiatric 
Institute, 
Henry  Avenue
 and 
Abbottsford 
Road, 
Philadelphia, 
Pennsylvania, 
19129 
USA,
Department 
of 
Psychiatry 
and Human 
Behavior, 
Jefferson 
Medical 
College, 
Philadelphia, 
Pennsylvania 
19107
 USA 

Role 
of 
Immunomodulation 
Therapy
 in 
Autoimmune 
Diabetes, 
Johnny 
Ludvigsson, 
M.D., 
Ph.D. 
for 
the Linköping 
Diabetes 
Immune
Intervention
 Study 
Group, 
Division
 of 
Pediatrics 
and 
Diabetes 
Research Centre, 
Department 
of 
Clinical
 and 
Experimental 
Medicine,
Linköping
 University, 
Sweden

"Separating
 wheat
 from 
chaff 
in
 celiac
 disease."  
Science 
News
 178.4
( 2010) :
 8.
 Web.
 25
 Oct
 2010.<http://www.sciencenews.org/view/generic/id/61321/title/Separating_wheat_from_chaff_in_celiac_disease>.

Sinclair,
 Mike. 
"Migraine 
prevention 
by 
targeting 
glutamate 
receptors?." 
BioMedicine. 
N.p., 
4/28/2009.  Web. 
22 
Sept 
2010. 
http://www.bio‐medicine.org/medicine‐news‐1/Migraine‐prevention‐by‐targeting‐ glutamate‐receptors‐3F‐43945‐1/


GO TO TOP OF PAGE
www.BioAcousticResearch.com


BioAcoustic Biology Research Studio investigates public information and research to incorporate every aspect of everything that affects public health and emotional peace of mind.   We are a Research/Education site.   Finding TRUE KNOWLEDGE is very hard these days.   We are committed to supplying you with all that we can find on a given subject, it is then up to you, to use YOUR DISCERNMENT, to truly know the reality we all share.   This is a research, education and self help site.  We are all in this together, the more EVERYONE KNOWS, the better off we ALL will be. 

 Disclaimer: the posting of stories, commentaries, reports, research, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.  This site is not affiliated with any government, religious, philosophical or political organizations.
Powered by Create your own unique website with customizable templates.